The Patient With Early Stage MF-CTCL

Slides:

Advertisements

Similar presentations

Radiation Therapy for CTCL- Then and Now.  Radiation Therapy  Radiation in CTCL  Radiation in the 70’s-90’s  Radiation today  Assumptions: background,

Advertisements

Dermatology Aspects of Cutaneous T-cell Lymphoma

Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.

Applying the New Multiple Sclerosis Guidelines to Clinical Practice

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions Chelsea.

The Nurse View.

CDK 4 and 6 Inhibitors in HR-Positive Breast Cancer: Implementing Paradigms in Clinical Practice.

Treatment Algorithms in Melanoma: Past, Present, and Future

Steps to Optimizing Outcomes in Patients With Advanced Prostate Cancer

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

Gout Management.

Updates in Hodgkin Lymphoma

A CASE CHALLENGE IN HFrEF:

Progression After Cancer Immunotherapy in Advanced NSCLC

Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.

Modern Strategies for Basal Insulin Use in T2D

Spotlight on Immuno-Oncology in Melanoma

Initial Diagnosis of MF-CTCL: A Collaborative Approach

Continuing the Advances in Relapsed/Refractory CLL: New Data, New Paradigms.

Clinical Cases in Glaucoma Treatment

All About PAH:.

Introduction. For Pulmonologists by Pulmonologists: Diagnosis of NSCLC in an Age of Biomarkers.

Novel and Emerging Approaches to Treating CLL

Precision Management of RA and Comorbidities

Checkpoint Inhibition

HCV Protease Inhibitors in Clinical Practice

The Emerging Role of Immunotherapy in Hodgkin Lymphoma

Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.

Exploring Personalized Prophylaxis in Hemophilia A

Current and Future Perspectives on Migraine Prevention Therapy

New Recommendations on How to Stage Hidradenitis Suppurativa

When Is Biologic Therapy Appropriate for HS?

Managing Polycythemia Vera in the Community Setting

Treating CD30-Expressing Cutaneous T-Cell Lymphoma

Improving Outcomes in Psoriatic Arthritis

Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Program Goals Overview Is NEDA a Reasonable Target?

Maintenance Therapy in Advanced Ovarian Cancer

When to Start and What to Use

The Road to Quality Improvement in HER2-Positive Breast Cancer

Understanding and Addressing the Needs of Patients With AD

Atopic Dermatitis in the Pediatric Practice

Psoriasis & skin cancer

Management of refractory early-stage cutaneous T-cell lymphoma (mycosis fungoides) with a combination of oral bexarotene and psoralen plus ultraviolet.

Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.

Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

Patient Questions and Expert Answers in Psoriasis:

HCV Protease Inhibitors in Clinical Practice

Management of Advanced Pancreatic Adenocarcinoma

Are We Making Progress in the Management of Huntington Disease?

Insulin in Diabetes Management: Effective Patient Selection Is Key

Critical Decision Points in Insomnia

Challenges in LA SCCHN.

Advanced Parkinson Disease: Are We Breaking New Ground?

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.

From Adjuvant to Metastatic in Melanoma

Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention.

Cutaneous T-Cell Lymphoma: Disease, Diagnosis, and Therapy

The Nurse View: Spotlight on EGFR-Mutated NSCLC

Finding the Right Sequence in Patients With EGFR-Mutated NSCLC

Maximizing Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer.

Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.

Exploring the Use of Adeno-Associated Virus for Gene Therapy

PHOENIX I: PASI 75 Response After 12 Weeks

Updates in Best Practices in Non-Small Cell Lung Cancer

Management of NTM Lung Disease

You Don't Know JAK in IBD.

Presentation transcript:

The Patient With Early Stage MF-CTCL

MF: Progression

Staging

MF/SS: Disease-Specific Survival in 1502 Patients

Cutaneous Lymphoma Treatments

Current Treatment Recommendations

Low-Dose TSEB in Patients With MF: UK Cutaneous Lymphoma Group

Targeted Therapy in CTCL

Stage-Dependent Treatment

Mechlorethamine*

Phototherapy: UVB and PUVA

Stage-Dependent Treatment

Adverse Event Management: Best Practices

Including the Patient's Perspective on Choice of Therapy

Key Issues for Treatment of MF

Concluding Remarks

Abbreviations